Legal professionals discussed AI developments in Latin America at IBA regional forum in Lima last week | 1yr
Legal professionals discussed AI developments in Latin America at IBA regional forum in Lima last week | 1yr
Keynote speakers from LCIA and the Commercial Court will open the event on 2 June | 1yr
Incoming hires include Abu Dhabi-based Din Eshanov and London-based George Kazakov | 1yr
Brad Karp details reasoning behind deal with Trump administration that saw executive order targeting firm withdrawn | 1yr
In-house legal teams are doing more pro bono work as a way to meet their business’s ESG goals | 1yr
Majority-female round follows top City independent posting double-digit revenue and profit growth for FY24 | 1yr
Brazil leads way on class action law in the region, but others such as Argentina lack specific legislation | 1yr
Highly rated M&A partner pledges to continue helping to ‘drive the firm forward’ | 1yr
Rachel Cohen helped coordinate letter signed by nearly 800 associates calling on law firm leaders to condemn Trump administration's “all-out attack” | 1yr
Jan Lang, who joins as a partner, is reunited with Alexander Israel, MoFo’s new EU competition head | 1yr
Keynote speaker Andrea de la Piedra says that despite increased diversity policies, change isn’t happening fast enough | 1yr
Anglo-Australian giant 'disappointed' by fine levied for ‘human error’ payments to sanctioned entities | 1yr
Latin American companies are having to navigate a ‘fragmented’ ESG landscape | 1yr
IBA president Jaime Carey and Peru’s central bank governor Julio Velarde headlined opening day’s sessions | 1yr
Anglo-German firm joins forces with Orsingher Ortu, boosting European credentials | 1yr
Project finance specialist Alexander Malahias joins ahead of planned office launch later this year | 1yr
SRA fund established through fines levied on Kaplan, the official SQE provider | 1yr
Women of the Year Charlotte Proudman and Monica Feria-Tinta among those honoured | 1yr
Round focused on UK, Europe and corporate lawyers nears gender parity | 1yr
AstraZeneca boasts highest market capitalisation of FTSE 100, at $185bn | 1yr